نتایج جستجو برای: 153sm

تعداد نتایج: 102  

Journal: :iranian journal of medical physics 0
fatemeh razghandi department of physics, school of sciences, ferdowsi university of mashhad, mashhad, iran reza izadi department of physics, school of sciences, ferdowsi university of mashhad, mashhad, iran ali mowlavi department of physics, hakim sabzevari university, sabzevar, iran international centre for theoretical physics, associate and federation schemes, medical physics field, trieste, italy

introduction one of the important applications of nuclear physics in medicine is the use of radioactive elements as radiopharmaceuticals. metastatic bone disease is the most common form of malignant bone tumors. samarium-153-ethylene diamine tetramethylene phosphonate (153sm-edtmp) as a radiopharmaceutical is used for pain palliation. this radiopharmaceutical usually emits beta particles, which...

Journal: :International journal of radiation biology 2017
Francisco D C Guerra Liberal Adriana Alexandre S Tavares João Manuel R S Tavares

PURPOSE Computational simulation is a simple and practical way to study and to compare a variety of radioisotopes for different medical applications, including the palliative treatment of bone metastases. This study aimed to evaluate and compare cellular effects modelled for different radioisotopes currently in use or under research for treatment of bone metastases using computational methods. ...

Journal: :Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2005
Corinne Planchamp Gerd J Beyer Daniel O Slosman François Terrier Catherine M Pastor

The aim was to study the influence of temperature on the transport of the hepatobiliary contrast agent Gadobenate dimeglumine (Gd-BOPTA). Rat livers were isolated and perfused with Gd-BOPTA at 12, 25, 30, 36 and 38 degrees C. After the perfusion period, biopsies were collected and the MR signal intensity was measured. Uptake and biliary excretion were quantified with radiolabeled Gd-BOPTA. MR s...

امیررضا جلیلیان ایوب آقانژاد صدیقه مرادخانی, علی بهرامی سامانی, مصطفی عرفانی نسیم وحیدفر

تهیه و تولید عوامل تسکین‌دهنده­‌ی درد استخوان برای بیمارانی که در مراحل نهایی سرطان قرار دارند، به طور روز افزونی در حال گسترش است. زولدرونیک اسید ](1-هیدروکسی-2-ایمیدازول-1-ایل- فسفونواتیل) فسفریک اسید مونو هیدرات[ نشان‌دار شده با 153Sm و 175Yb می‌­تواند به عنوان عوامل درمانی بالقوه جهت درمان تسکینی استخوان استفاده شود. در این مطالعه، کمپلکس‌های زولدرونیک اسید-153Sm و زولدرونیک اسید-175Yb با ا...

Journal: :asia oceania journal of nuclear medicine and biology 0
narjess ayati nuclear medicine research center, mashhad university of medical science, faculty of medicine, mashhad, iran kamran aryana nuclear medicine research center, mashhad university of medical science, faculty of medicine, mashhad, iran amir jalilian radiopharmaceutical research & development laboratory (rrdl), nuclear science and technology research institute (nstri), tehran, iran toktam hoseinnejad nuclear medicine research center, mashhad university of medical science, faculty of medicine, mashhad, iran ali bahrami samani radiopharmaceutical research & development laboratory (rrdl), nuclear science and technology research institute (nstri), tehran, iran zahra ayati school of pharmacy, mashhad university of medical science, mashhad, iran

introduction: involvement of the skeleton can cause an excruciating pain in two-thirds of terminal patients with a history of malignancy. due to several limitations of other therapies, such as analgesics, bisphosphonates, chemotherapy, hormonal therapy and external beam radiotherapy; bone-seeking radiopharmaceuticals have an important role in palliation of pain from bone metastases. although th...

Journal: :iranian journal of nuclear medicine 2010
ali bahrami-samani amir reza jalilian hassan yousefnia mehdi akhlaghi mohammad mazidi

introduction: developing new radiosynovectomy agents is of great importance due to the aging of human populations around the world and increasing the incidence of inflammatory diseases. in this work, sm-153 chitosan agent was developed for the first time in our country and preparation and quality control of the compound is described. methods: sm-153 chloride was obtained by thermal neutron flu...

Journal: :iranian journal of radiation research 0
z. naseri school of chemistry, university college of science, university of tehran, iran a. hakimi health physics and dosimetry research laboratory, department of physics, amir kabir university of technology, tehran, iran s. shirvani-arani radiopharmaceutical research and development lab (rrdl), nuclear science and technology research institute (nstri), tehran, iran a.r. jalilian radiopharmaceutical research and development lab (rrdl), nuclear science and technology research institute (nstri), tehran, iran a. bahrami-samani radiopharmaceutical research and development lab (rrdl), nuclear science and technology research institute (nstri), tehran, iran m. nemati kharat school of chemistry, university college of science, university of tehran, iran

background: the 153sm-[tris(1,10-phenanthroline) samarium(iii)]complex (153sm-pl3) was prepared in view of development of targeting therapeutic compounds for malignancies, and interesting in-vitro anti-tumor activities of lanthanide phenanthroline complexes,. materials and methods: sm-153 chloride was obtained by thermal neutron flux (4 × 1013 n.cm-2.s-1) of enriched 152sm2o3 sample, dissolved ...

Ali Mowlavi, Fatemeh Razghandi Reza Izadi,

Introduction One of the important applications of nuclear physics in medicine is the use of radioactive elements as radiopharmaceuticals. Metastatic bone disease is the most common form of malignant bone tumors. Samarium-153-ethylene diamine tetramethylene phosphonate (153Sm-EDTMP) as a radiopharmaceutical is used for pain palliation. This radiopharmaceutical usually emits beta particles, which...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید